These data suggest that TE-2 targets cellular oxidoreductases (i.e. TrxR1), required for the conformational changes in gp120 upon viral infection of the target cells, rather than a virus-encoded (glyco)protein such as gp120 or gp41. This evidence concerns the gene TXNRD1 and viral infectious disease.